Abacavir Sulfate (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Abacavir Sulfate drug offered from Mylan Pharmaceuticals Inc.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | abacavir sulfate |
SUBSTANCE NAME: | ABACAVIR SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-06-19 |
END MARKETING DATE: | 0000-00-00 |
Abacavir Sulfate HUMAN PRESCRIPTION DRUG Details:
Item Description | Abacavir Sulfate from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/1) |
START MARKETING DATE: | 2012-06-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-4105_17fde9d3-7eae-4969-b659-5dbcf512a298 |
PRODUCT NDC: | 0378-4105 |
APPLICATION NUMBER: | ANDA091294 |
Other ABACAVIR SULFATE Pharmaceutical Manufacturers / Labelers: